Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Director departure
OMNI BIO PHARMACEUTICAL, INC. (OMBP) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/24/2015 8-K Form 8-K - Current report
05/07/2015 8-K Other Events
04/09/2015 SC 13D/A BOCO Investments LLC reports a 36% stake in OMNI BIO PHARMACEUTICAL, INC.
03/13/2015 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Even...
Docs: "Second Amended Secured Convertible Promissory Note of Omni Bio Pharmaceutical, Inc. dated April 25, 2014, executed March 12, 2015",
"Second Modification and Exchange Agreement between Omni Bio Pharmaceutical, Inc. and Bohemian Investments, LLC., executed March 12, 2015"
02/17/2015 10-Q Quarterly Report for the period ended December 31, 2014
02/02/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Amended Secured Convertible Promissory Note of Omni Bio Pharmaceutical, Inc. dated April 25, 2014, executed January 29, 2015",
"Modification and Exchange Agreement between Omni Bio Pharmaceutical, Inc. and Bohemian Investments, LLC., executed January 29,2015"
01/07/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment to Employment Agreement between Omni Bio Pharmaceutical, Inc. and Bruce E. Schneider"
11/13/2014 10-Q Quarterly Report for the period ended September 30, 2014
10/20/2014 8-K Other Events
09/11/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Corporate Presentation of Omni Bio Pharmaceutical, Inc. posted September 11, 2014"
08/14/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement dated August 6, 2014, between Omni Bio Pharmaceutical, Inc. and Jack Riccardi",
"Omni Bio Appoints Jack Riccardi as Chief Financial Officer Fort Collins, CO, August 14, 2014 – Omni Bio Pharmaceutical, Inc. , an emerging biopharmaceutical company focused on revolutionizing the treatment of immune-mediated inflammatory diseases, announced today the appointment of Jack Riccardi as its Chief Financial Officer. Mr. Riccardi brings more than 30 years of financial leadership experience. He was formerly CFO of ADial Pharmaceuticals and served most recently as CFO and Partner at Green Street Ventures. Mr. Riccardi’s appointment will become effective on September 1, 2014. Bruce Schneider, Ph.D., Chief Executive Officer of Omni Bio, commented, “As Omni Bio continues to evolve its business, we are very pleased to add such a seasoned financial leader to our team. Jack has a proven ..."
08/13/2014 10-Q Quarterly Report for the period ended June 30, 2014
06/16/2014 10-K Annual Report for the period ended March 31, 2014
06/02/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Corporate Presentation of Omni Bio Pharmaceutical, Inc."
04/29/2014 8-K Entry into a Material Definitive Agreement
04/25/2014 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Loan and Warrant Purchase Agreement, between Bohemian Investments, LLC and Omni Bio Pharmaceutical, Inc.",
"Warrant issued to Bohemian Investments, LLC",
"Warrant issued to BOCO Investments, LLC"
03/07/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/14/2014 10-Q Quarterly Report for the period ended December 31, 2013
01/06/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment to Employment Agreement between Omni Bio Pharmaceutical, Inc. and Bruce E. Schneider"
11/26/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Press Release of Omni Bio Pharmaceutical, Inc."
11/14/2013 10-Q Quarterly Report for the period ended September 30, 2013
11/06/2013 8-K Form 8-K - Current report
08/14/2013 10-Q Quarterly Report for the period ended June 30, 2013
07/17/2013 8-K Appointed a new director
Docs: "Press Release of Omni Bio Pharmaceutical, Inc."
06/28/2013 10-K Annual Report for the period ended March 31, 2013
06/10/2013 SC 13D Mooney Frank Steven reports a 20% stake in Omni Bio Pharmaceutical, Inc.
02/14/2013 10-Q Quarterly Report for the period ended December 31, 2012
02/12/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Corporate Presentation of Omni Bio Pharmaceutical, Inc."
11/14/2012 10-Q Quarterly Report for the period ended September 30, 2012
10/05/2012 8-K Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce...
10/02/2012 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Exclusive License Agreement with the Regents of the University of Colorado"
09/28/2012 SC 13G/A Mooney Frank Steven reports a 18.4% stake in Omni Bio Pharmaceutical, Inc.
08/27/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/14/2012 10-Q Quarterly Report for the period ended June 30, 2012
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy